Dexmedetomidine Attenuates Glutamate-Induced Cytotoxicity by Inhibiting the Mitochondrial-Mediated Apoptotic Pathway
- PMID: 32419697
- PMCID: PMC7251967
- DOI: 10.12659/MSM.922139
Dexmedetomidine Attenuates Glutamate-Induced Cytotoxicity by Inhibiting the Mitochondrial-Mediated Apoptotic Pathway
Abstract
BACKGROUND Glutamate (GLU) is the most excitatory amino acid in the central nervous system and plays an important role in maintaining the normal function of the nervous system. During cerebral ischemia, massive release of GLU leads to neuronal necrosis and apoptosis. It has been reported that dexmedetomidine (DEX) possesses anti-oxidant and anti-apoptotic properties. The objective of this study was to investigate the effects of DEX on GLU-induced neurotoxicity in PC12 cells. MATERIAL AND METHODS PC12 cells were treated with 20 mM GLU to establish an ischemia-induced injury model. Cell viability was accessed by MTT assay. MDA content and SOD activity were analyzed by assay kits. Apoptosis rate, ROS production, intracellular Ca²⁺ concentration, and MMP were evaluated by flow cytometry. Western blot analysis was performed to analyze expressions of caspase-3, caspase-9, cyt-c, bax, and bcl-2. RESULTS PC12 cells treated with GLU exhibited reduced cell viability and increased apoptosis rates, which were ameliorated by pretreatment with DEX. DEX significantly increased SOD activity, reduced content of MDA, and decreased production of ROS in PC12 cells. In addition, DEX clearly reduced the level of intracellular Ca²⁺ and attenuated the decline of MMP. Moreover, DEX notably reduced expressions of caspase-3, caspase-9, cyt-c, and bax and increased expression of bcl-2. CONCLUSIONS Our findings suggest that DEX can protect PC12 cells against GLU-induced cytotoxicity, which may be attributed to its anti-oxidative property and reduction of intracellular calcium overload, as well as its ability to inhibit the mitochondria-mediated apoptotic pathway.
Conflict of interest statement
None.
Figures





Similar articles
-
[Protective effect of dexmedetomidine against glutamate-induced cytotoxicity in PC12 cells and its mechanism].Nan Fang Yi Ke Da Xue Xue Bao. 2016 Feb 20;37(2):150-156. doi: 10.3969/j.issn.1673-4254.2017.02.02. Nan Fang Yi Ke Da Xue Xue Bao. 2016. PMID: 28219856 Free PMC article. Chinese.
-
Protective effect of dexmedetomidine on neuronal hypoxic injury through inhibition of miR-134.Hum Exp Toxicol. 2021 Dec;40(12):2145-2155. doi: 10.1177/09603271211023784. Epub 2021 Jun 14. Hum Exp Toxicol. 2021. PMID: 34121490
-
Dexmedetomidine Protects Against Chemical Hypoxia-Induced Neurotoxicity in Differentiated PC12 Cells Via Inhibition of NADPH Oxidase 2-Mediated Oxidative Stress.Neurotox Res. 2019 Jan;35(1):139-149. doi: 10.1007/s12640-018-9938-7. Epub 2018 Aug 15. Neurotox Res. 2019. PMID: 30112693
-
Dexmedetomidine alleviates hepatic injury via the inhibition of oxidative stress and activation of the Nrf2/HO-1 signaling pathway.Eur Cytokine Netw. 2019 Sep 1;30(3):88-97. doi: 10.1684/ecn.2019.0431. Eur Cytokine Netw. 2019. PMID: 31957703
-
Protective effects of dexmedetomidine in vital organ injury: crucial roles of autophagy.Cell Mol Biol Lett. 2022 May 4;27(1):34. doi: 10.1186/s11658-022-00335-7. Cell Mol Biol Lett. 2022. PMID: 35508984 Free PMC article. Review.
Cited by
-
Molecular mechanisms and therapeutic strategies of GPX4 regulation in acute kidney injury.Pharmacol Rep. 2025 Aug 28. doi: 10.1007/s43440-025-00777-8. Online ahead of print. Pharmacol Rep. 2025. PMID: 40866755 Review. No abstract available.
-
Study on the mechanism of Dexmedetomidine's effect on postoperative cognitive dysfunction in elderly people.Front Physiol. 2025 Mar 12;16:1508661. doi: 10.3389/fphys.2025.1508661. eCollection 2025. Front Physiol. 2025. PMID: 40144543 Free PMC article. Review.
-
Dexmedetomidine Ameliorates Postoperative Cognitive Dysfunction in Aged Mice.Neurochem Res. 2021 Sep;46(9):2415-2426. doi: 10.1007/s11064-021-03386-y. Epub 2021 Jun 23. Neurochem Res. 2021. PMID: 34159456
-
The role of anesthesia in peri‑operative neurocognitive disorders: Molecular mechanisms and preventive strategies.Fundam Res. 2023 Feb 24;4(4):797-805. doi: 10.1016/j.fmre.2023.02.007. eCollection 2024 Jul. Fundam Res. 2023. PMID: 39161414 Free PMC article. Review.
-
Mitochondrial Protection and Against Glutamate Neurotoxicity via Shh/Ptch1 Signaling Pathway to Ameliorate Cognitive Dysfunction by Kaixin San in Multi-Infarct Dementia Rats.Oxid Med Cell Longev. 2021 Jul 9;2021:5590745. doi: 10.1155/2021/5590745. eCollection 2021. Oxid Med Cell Longev. 2021. PMID: 34306310 Free PMC article.
References
-
- Del Bene A, Palumbo V, Lamassa M, et al. Progressive lacunar stroke: Review of mechanisms, prognostic features, and putative treatments. Int J Stroke. 2012;7:321–29. - PubMed
-
- Zhou M, Offer A, Yang G, et al. Body mass index, blood pressure, and mortality from stroke: A nationally representative prospective study of 212,000 Chinese men. Stroke. 2008;39:753–59. - PubMed
-
- Christophe BR, Mehta SH, Garton AL. Current and future perspectives on the treatment of cerebral ischemia. Expert Opin Pharmacother. 2017;18:573–80. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous